Andrew A. Wagner, MD, an instructor in surgery at Harvard Medical School, Boston, has joined the division of urology as director of minimally invasive urologic surgery in the Roberta and Stephen R. Weiner Department of Surgery at Beth Israel Deaconess Medical Center (BIDMC). Wagner is a resident of Newton.
In addition to providing general urological care, he is an expert in laparoscopic surgery for simple and complex kidney and prostate disorders and offers minimally invasive surgical treatment for many urological disorders, including benign and malignant prostate disorders, renal tumors, renal obstruction, and urinary calculi. His research interests include non-invasive radiosurgical (CyberKnife®) treatment of small renal tumors, quality of life differences between open and laparoscopic kidney surgery, and quality of life following minimally invasive treatment for prostate cancer. At BIDMC, he will lead efforts in expanding minimally invasive approaches for the treatment of benign and malignant urologic conditions with a focus on kidney and prostate surgery, including carcinoma of the prostate.
Wagner received his medical degree from the State University of New York at Buffalo School of Medicine and Biomedical Sciences in Buffalo, New York. He completed intern and resident training in general surgery, and resident training in urology, at the University of Massachusetts School of Medicine in Worcester, Massachusetts. He comes to BIDMC after completing fellowship training in laparoscopy and minimally invasive urology at Johns Hopkins Medical Institutions, Brady Urological Institute, in Baltimore.
Beth Israel Deaconess Medical Center is a major patient care, teaching and research affiliate of Harvard Medical School, and ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a founding member of the Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox.